OrbiMed’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Sell |
|
|||||
|
2025
Q1 | $9.32M | Hold |
|
|||||
|
2024
Q4 | $12.2M | Hold |
|
|||||
|
2024
Q3 | $10.9M | Hold |
|
|||||
|
2024
Q2 | $12.4M | Hold |
|
|||||
|
2024
Q1 | $18.9M | Hold |
|
|||||
|
2023
Q4 | $23.9M | Hold |
|
|||||
|
2023
Q3 | $19.2M | Hold |
|
|||||
|
2023
Q2 | $27M | Hold |
|
|||||
|
2023
Q1 | $31.5M | Hold |
|
|||||
|
2022
Q4 | $42.4M | Hold |
|
|||||
|
2022
Q3 | $41.3K | Hold |
|
|||||
|
2022
Q2 | $44.5K | Hold |
|
|||||
|
2022
Q1 | $40.8M | Hold |
|
|||||
|
2021
Q4 | $59.8M | Hold |
|
|||||
|
2021
Q3 | $83.8M | Sell |
|
|||||
|
2021
Q2 | $137M | Sell |
|
|||||
|
2021
Q1 | $278M | Sell |
|
|||||
|
2020
Q4 | $338M | Buy |
|